News49 seconds ago
EMA validates marketing authorisation application for efanesoctocog alfa for treatment of haemophilia A
STOCKHOLM, May 19, 2023 /PRNewswire/ — Sobi today announced that the European Medicines Agency (EMA) has accepted and validated a marketing authorisation application for efanesoctocog alfa,...
